logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

HR+/HER2- advanced breast cancer: efficacy of CDK4/6 inhibitors confirmed

Meta-analysis finds better OS, PFS, ORR, and clinical benefit rate.